CHEPLAPHARM

Mesekenhagen, Germany Founded: 1998 • Age: 28 yrs
Branded pharmaceutical products are developed, marketed, and distributed globally.
Request Access

About CHEPLAPHARM

CHEPLAPHARM is a company based in Mesekenhagen (Germany) founded in 1998 by Kurt Teubner.. The company has 840 employees as of December 31, 2021. CHEPLAPHARM offers products and services including Specialty Pharmaceutical Products. CHEPLAPHARM operates in a competitive market with competitors including AmerisourceBergen, WuXi AppTec, FundaMental Pharma, PHOENIX group and CeGaT, among others.

  • Headquarter Mesekenhagen, Germany
  • Employees 840 as on 31 Dec, 2021
  • Founders Kurt Teubner
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cheplapharm Arzneimittel Gmbh
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $547 M (USD), Debt – Convertible

    Oct 25, 2022

  • Investors
    HSBC

    & 5 more

  • Employee Count
    840

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CHEPLAPHARM

CHEPLAPHARM offers a comprehensive portfolio of products and services, including Specialty Pharmaceutical Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Acquired and developed branded drugs for global markets

People of CHEPLAPHARM
Headcount 50-200
Employee Profiles 15
Employee Profiles
People
Klaus Köhl
COO
People
Edeltraud Lafer
Co-CEO
People
Sebastian Braun
Co-CEO
People
Christian Kerkhoff
Head Of Strategic Procurement - External Manufacturing

Unlock access to complete

Funding Insights of CHEPLAPHARM

  • Total Funding
  • Total Rounds 4
  • Last Round Debt – Convertible — $547.0M
  • First Round

    (26 Oct 2016)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Debt – Convertible - CHEPLAPHARM Valuation GIC , Atlantic Park
Nov, 2018 Amount Debt – Conventional - CHEPLAPHARM Valuation

investors

Jul, 2018 Amount Debt – Conventional - CHEPLAPHARM Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CHEPLAPHARM

CHEPLAPHARM has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HSBC, Deutsche Bank and UniCredit. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Sovereign wealth is managed and private equity investments are facilitated.
Founded Year Domain Location
-
Founded Year Domain Location
A family office is operated across Nordic and European regions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CHEPLAPHARM

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CHEPLAPHARM

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cheplapharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CHEPLAPHARM

CHEPLAPHARM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, WuXi AppTec, FundaMental Pharma, PHOENIX group and CeGaT, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical distribution and supply chain services are provided globally.
domain founded_year HQ Location
Provider of CRO and CDMO services
domain founded_year HQ Location
Provider of drug development & research services for peptides & gene therapy, and neurological diseases
domain founded_year HQ Location
Leading European provider of pharmaceutical wholesale, retail, and supply chain services.
domain founded_year HQ Location
Provider of drug research and development services to develop genetic causes of rare diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cheplapharm

Frequently Asked Questions about CHEPLAPHARM

When was CHEPLAPHARM founded?

CHEPLAPHARM was founded in 1998 and raised its 1st funding round 18 years after it was founded.

Where is CHEPLAPHARM located?

CHEPLAPHARM is headquartered in Mesekenhagen, Germany. It is registered at Mesekenhagen, Mecklenburg-vorpommern, Germany.

How many employees does CHEPLAPHARM have?

As of Dec 31, 2021, the latest employee count at CHEPLAPHARM is 840.

What does CHEPLAPHARM do?

Cheplapharm was established in 1998 as a family-run pharmaceutical company headquartered in Mesekenhagen, Germany. Operations focus on the development, marketing, and distribution of branded products across various therapeutic areas. The portfolio has been expanded through strategic acquisitions and partnerships, supporting worldwide distribution. As a specialty pharmaceutical entity, investments are directed toward long-established brands in the sector.

Who are the top competitors of CHEPLAPHARM?

CHEPLAPHARM's top competitors include AmerisourceBergen, WuXi AppTec and SCHOTT Pharma.

What products or services does CHEPLAPHARM offer?

CHEPLAPHARM offers Specialty Pharmaceutical Products.

Who are CHEPLAPHARM's investors?

CHEPLAPHARM has 6 investors. Key investors include HSBC, Deutsche Bank, UniCredit, GIC, and Atlantic Park.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available